Motley Fool Speculates About Fresenius Purchase of NxStage
Will NxStage stock price volatility affect he sale of NxStage to purchaser Fresenius Medical Care? Time will tell, and revenues are up, but profits are not.
Read the full article » | Posted 06-12-2018
Related Articles
- NKF 2025 Survey: Patients Want More Home Dialysis Options Posted 01-13-2025
- Annual PD Machine Operating Cost is $24/mo or Less Posted 01-13-2025
- Premier Dialysis Videos: How to Read and Use PD Bags From Other Countries Posted 01-13-2025
- Medicare’s 2025 Physician Fee Schedule Posted 01-13-2025